Apolipoprotein (apo) E4 and Alzheimer's disease: unique conformational and biophysical properties of apoE4 can modulate neuropathology.
about
Interactions of metals and Apolipoprotein E in Alzheimer's diseaseStudy of the ketogenic agent AC-1202 in mild to moderate Alzheimer's disease: a randomized, double-blind, placebo-controlled, multicenter trialApolipoprotein E: isoform specific differences in tertiary structure and interaction with amyloid-β in human Alzheimer brainPathway network inference from gene expression data.Hippocampal volumes are important predictors for memory function in elderly women.Increased functional brain response during word retrieval in cognitively intact older adults at genetic risk for Alzheimer's disease.Role of vascular risk factors and vascular dysfunction in Alzheimer's disease.Molecular signatures in post-mortem brain tissue of younger individuals at high risk for Alzheimer's disease as based on APOE genotype.Ketone bodies as a therapeutic for Alzheimer's disease.Autophagy failure in Alzheimer's disease--locating the primary defect.On control of singleton attractors in multiple Boolean networks: integer programming-based methodAge and apolipoprotein E ε4 effects on neural correlates of odor memoryWhether Alzheimer's diseases related genes also differently express in the hippocampus of Ts65Dn mice?Autophagy and neuronal cell death in neurological disordersElevated Neuronal Excitability Due to Modulation of the Voltage-Gated Sodium Channel Nav1.6 by Aβ1-42.APOE ɛ4, an Alzheimer's disease susceptibility allele, and smoking cessation.Cholesterol-related genetic risk scores are associated with hypometabolism in Alzheimer's-affected brain regions.Hydration dynamics in a partially denatured ensemble of the globular protein human alpha-lactalbumin investigated with molecular dynamics simulations.Apolipoprotein E epsilon4 is associated with disease-specific effects on brain atrophy in Alzheimer's disease and frontotemporal dementiaOcular HSV-1 latency, reactivation and recurrent disease.APOE genotype modifies the relationship between midlife vascular risk factors and later cognitive decline.Lack of association of the APOE epsilon 4 allele with the risk of obstructive sleep apnea: meta-analysis and meta-regressionApolipoprotein E4 domain interaction induces endoplasmic reticulum stress and impairs astrocyte function.Common variants in psychiatric risk genes predict brain structure at birth.In silico analyses of deleterious missense SNPs of human apolipoprotein E3.Disorders of lysosomal acidification-The emerging role of v-ATPase in aging and neurodegenerative disease.Genetic Factors Affecting Late-Onset Alzheimer's Disease Susceptibility.Contributions of the carboxyl-terminal helical segment to the self-association and lipoprotein preferences of human apolipoprotein E3 and E4 isoforms.APOEε4 and slow wave sleep in older adults.Apolipoprotein E as a novel therapeutic neuroprotection target after traumatic spinal cord injury.Intraneuronal amyloid-beta plays a role in mediating the synergistic pathological effects of apoE4 and environmental stimulation.Exploring the effect of the apolipoprotein E (APOE) gene on executive function, working memory, and processing speed during the early recovery period following traumatic brain injury.Gender, apolipoprotein E genotype, and mesial temporal atrophy: 2-year follow-up in patients with stable mild cognitive impairment and with progression from mild cognitive impairment to Alzheimer's disease.
P2860
Q21131068-621DB281-2CB9-4724-8820-E20325EEFF16Q21245063-296D167C-3C58-48F3-A33B-613110000DFAQ28477020-B16F38FE-FB4D-4876-9CEB-56393C70AD8DQ30836899-0F7878FC-FC94-4AC9-B529-17B22FA2CEE3Q33495745-AC446359-DD05-4543-BAAA-82F55A1AEA66Q33823353-F776DCF7-2773-4F20-AEE6-2F7B803CA311Q34055011-EAA7DA71-8FA3-4559-B2D4-05E96DDDD38EQ34192190-F14FC979-66E2-420C-98C2-86FB696145C1Q34795761-3D0DD18B-901B-49A3-9049-CD0C8AAF0314Q34987827-0F78ECE9-BF13-4E08-B624-37FC66612E2CQ35102169-8BE2D91A-369E-41D3-9146-EAF5CF908288Q35117343-88C6768A-4500-4818-AA48-4269F4728F92Q35741170-99F835B4-3519-4DE5-BC80-71B45022D634Q36329444-14F3B4C7-DA67-402C-A1AA-D729E82CDA7BQ36665599-C6B52B51-5C37-4D6D-8BD2-7CA84B826A40Q36703942-6FD1FB1B-8B8B-433F-A487-BF98274BD67DQ36740538-E2972082-25D7-4553-8CE2-AD66F2546256Q36981723-1B88A34B-F4BF-4AF0-8E21-442E938CE850Q37100964-BB064686-DC8E-4C92-8333-C697AD12F592Q37201603-9CA3CBF7-3D0D-4D8D-AC4B-3BEB8B7C1199Q37360798-B8EE86A7-E349-49DA-940C-377494E384EAQ37402583-721AB063-60ED-4E2E-90BF-DC8698100E52Q37447983-FC14B7D9-A661-42F9-A6D8-9EE03C2F0032Q37688290-18FAFF1C-269F-4DC6-B716-E53833323A72Q38755492-4CA7474B-5F1B-4FC0-ADB6-AF184B185BE1Q38838536-9237F280-64FB-4401-B04E-42CF0B9BD837Q41136953-9B2BE007-3C8D-4C72-94EE-882E701D7E48Q42173744-A493107C-B6FD-4114-A924-883C265B065EQ47551911-37249242-FA2D-428D-BD2A-CF9F394FABEFQ47619892-972BE703-44A8-407C-BB9E-EB56D8CC8ADBQ48089465-3EA9D4DA-021A-4158-9020-D3099CF55F96Q48890844-9C664A3A-BE98-48BE-AA02-265358F112FBQ53035410-F0153577-1FA6-48AD-A6EB-69C430F6490C
P2860
Apolipoprotein (apo) E4 and Alzheimer's disease: unique conformational and biophysical properties of apoE4 can modulate neuropathology.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Apolipoprotein (apo) E4 and Al ...... 4 can modulate neuropathology.
@ast
Apolipoprotein (apo) E4 and Al ...... 4 can modulate neuropathology.
@en
type
label
Apolipoprotein (apo) E4 and Al ...... 4 can modulate neuropathology.
@ast
Apolipoprotein (apo) E4 and Al ...... 4 can modulate neuropathology.
@en
prefLabel
Apolipoprotein (apo) E4 and Al ...... 4 can modulate neuropathology.
@ast
Apolipoprotein (apo) E4 and Al ...... 4 can modulate neuropathology.
@en
P2860
P1476
Apolipoprotein (apo) E4 and Al ...... 4 can modulate neuropathology.
@en
P2093
P2860
P356
10.1111/J.1600-0404.2006.00679.X
P577
2006-01-01T00:00:00Z